Bellicum Pharmaceuticals Pink Sheet Forecast - Accumulation Distribution
| BLCMDelisted Stock | USD 0.37 0.05 11.90% |
Bellicum Pink Sheet Forecast is based on your current time horizon.
Bellicum |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 12941.84 | 15607.89 |
| Check Bellicum Pharmaceuticals Volatility | Backtest Bellicum Pharmaceuticals | Trend Details |
Bellicum Pharmaceuticals Trading Date Momentum
| On May 03 2023 Bellicum Pharmaceuticals was traded for 0.38 at the closing time. The top price for the day was 0.38 and the lowest listed price was 0.34 . The trading volume for the day was 91 K. The trading history from May 3, 2023 was a factor to the next trading day price boost. The overall trading delta against the next closing price was 2.70% . The overall trading delta against the current closing price is 210.81% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
Compare Bellicum Pharmaceuticals to competition
Bellicum Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bellicum Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Bellicum Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Bellicum Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Bellicum Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Bellicum Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bellicum Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Bellicum Pharmaceuticals pink sheet market strength indicators, traders can identify Bellicum Pharmaceuticals entry and exit signals to maximize returns.
Bellicum Pharmaceuticals Risk Indicators
The analysis of Bellicum Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Bellicum Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting bellicum pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 12.36 | |||
| Semi Deviation | 14.01 | |||
| Standard Deviation | 26.49 | |||
| Variance | 701.48 | |||
| Downside Variance | 257.21 | |||
| Semi Variance | 196.27 | |||
| Expected Short fall | (18.85) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Bellicum Pink Sheet
If you are still planning to invest in Bellicum Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bellicum Pharmaceuticals' history and understand the potential risks before investing.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |